行情

MYOS

MYOS

MYOS RENS
NASDAQ

实时行情|Nasdaq Last Sale

0.9700
+0.0700
+7.78%
已收盘, 16:00 04/03 EDT
开盘
0.9000
昨收
0.9000
最高
0.9700
最低
0.9000
成交量
7,557
成交额
--
52周最高
1.800
52周最低
0.7412
市值
1,053.17万
市盈率(TTM)
-2.0004
分时
5日
1月
3月
1年
5年

目标价格预测

分析师预测MYOS价格均价为3.750,最高价位3.750,最低价为3.750。

EPS

MYOS 新闻

更多
  • 印尼股市自3月24日低点累计上涨20% 进入技术性牛市
  • 新浪财经 · 2小时前
  • 华尔街大佬预计标普500最惨或跌至1500点
  • 新浪财经 · 2小时前
  • 波音公司华盛顿州生产基地将无限期停工
  • 中国新闻网 · 2小时前
  • 安倍最快明天宣布日本进入紧急状态,拟以东京和大阪为主
  • 澎湃新闻 · 3小时前

所属板块

食品加工
+1.34%
食品和烟类
+0.71%

热门股票

代码
价格
涨跌幅

MYOS 简况

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
展开

微牛提供MYOS RENS Technology Inc(NASDAQ-MYOS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的MYOS股票新闻,以帮助您做出投资决策。